European Directorate for the Quality of Medicines and Healthcare
In 2022, SNOMED International and the European Directorate for the Quality of Medicines and Healthcare (EDQM) signed a collaboration agreement to work on aligning SNOMED CT and EDQM standard dose forms.
The Member led Drug Extension User Support Group (DEUSG) of SNOMED International identified the need for a map between EDQM Standard Terms and SNOMED CT dose forms to serve the following use cases:
To represent real / branded medication products in a SNOMED CT drug extension, based on the registered product information (where EDQM Standard Terms dose forms are used for regulatory purposes).
To map medicinal products from a national or local medicinal product dictionary to internationally agreed SNOMED CT Clinical Drugs, for interoperability purposes, such as the sharing of medication lists for cross-border patient-care, pharmacovigilance and clinical research.
To map from an IDMP-compliant regulatory database of medicinal products to SNOMED CT drug concepts (which include the dose form).
The work has been completed on aligning the SNOMED CT dose forms with those in EDQM Standard Terms, where in scope of SNOMED CT. A map has been created from EDQM Standard Terms to SNOMED CT dose forms and reviewed by experts. An Alpha release will be available for wider review and feedback in January 2023 with the aim of the first production release being available in Q2, 2023.
January 2023: SNOMED and the EDQM collaborate on map development